@FierceMedDev: GE VC arm will not be impacted by sale of GE Capital. Updated story | Follow @FierceMedDev
@VarunSaxena2: ICYMI from FierceDiagnostics: FDA announces LuSys Labs' recall of its unapproved Ebola diagnostic. Story | Follow @VarunSaxena2
@EmilyWFierce: Roche grabs CAPP Medical to gain ground in cancer Dx. FierceDiagnostics article | Follow @EmilyWFierce
> Royal Philips ($PHG) has introduced a mobile app for nurses to monitor patient alarms and to provide an almost real-time view of their vital signs. More
> Tendyne has started a multi-center, global trial of its Bioprosthetic Mitral Valve System to treat patients with symptomatic mitral regurgitation of degenerative or functional etiology. More
> Scientists have created a device that attaches to cell phones and can create holograms of cells to diagnose diseases such as cervical cancer. Story
Biotech News
@FierceBiotech: ICYMI yesterday: After PhIII odyssey, the FDA finally gives Medicines Co a thumbs-up for cangrelor. Report | Follow @FierceBiotech
@JohnCFierce: Roche hustles its PD-L1 'breakthrough' star into 11 late-stage trials. News | Follow @JohnCFierce
> New data on GW Pharma's cannabis-based epilepsy drug stokes hopes of success. Report
> Incyte is opening an R&D command center in Geneva. Story
> Bayer hits the gas on its top cancer prospect with Phase III in sight. Article
Pharma News
@FiercePharma: Valeant CEO's 2014 pay pales in comparison to new EVP's $50M-plus. Article | Follow @FiercePharma
@EricPFierce: ICYMI: Here's Baxter release on recall of 8 saline lots, 4 dextrose, 3 Lactated Ringer's Injection. Release | Follow @EricPFierce
> Merck's Frazier joins top-paid pharma CEOs with a $25M package. Report
> Actavis says it'll lose $200M in Namenda sales if appeals court nixes a 'hard switch.' Story
> Currency hurts, Olysio plummets, but J&J pharma growth carries on. Article
Drug Delivery News
> J&J to use drug delivery device for HBV vaccine thanks to $85M partnership. Item
> 'BLAST' laser method allows large particle delivery to 100,000 cells per minute. Article
> KemPharm sets IPO price for up to $56 million. Report
> Israel's Intec discussing $150M drug delivery partnership with Big Pharma company. More
> Developer of surgically delivered microparticles to brain gets $72.5M in latest funding round. News
Pharma Manufacturing News
> Walgreens CEO hints at another supply chain deal. Item
> Actavis asks court to let it stop manufacturing older Alzheimer's treatment. Item
> Vectura will close plant in Germany within the year. Report
> Baxter again having to recall saline solution as shortage persists. Story
> Novo opens $100M plant in Russia. Article
Pharma Asia News
> IDT Australia release on FDA nod for 23 generics begs the question: Where's the beef? Story
> Australia's George Clinical eyes China drug discovery going global. More
> Takeda names U.S. head, bringing first woman to executive team. Report
> India moves partially on bar codes for exported drugs by July. Story
> TVM closes on $50M for China Biopharma plans. Article